← SynDRA

DEXAMETHASONE ACETATE

SynDRA canonical compound SYN0025505 — structure-anchored drug synonym record

Clinical phaseLaunched
Approval statusApproved · OTC
Primary target(s)NR3C1
Mechanism of actionGlucocorticoid receptor agonist
Indicationallergic rhinitis | anemia | dermatitis herpetiformis (DH) | enteritis | hypercalcemia | lupus | multiple sclerosis | nephrotic syndrome | osteoarthritis | psoriasis | psoriatic arthritis | rheumatoid arthritis | ulcerative colitis
Disease areaallergy | dermatology | endocrinology | gastroenterology | hematology | neurology/psychiatry | rheumatology

All known targets

Mechanisms of action (all sources)

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

Drug classes

ATC classes

Cross-references

Synonyms

Reported adverse events

Look up DEXAMETHASONE ACETATE in the interactive SynDRA portal →